Studies have indicated that the low levels of HDAC activity in bronchial biopsies and AMs of patients with COPD are closely associated with HDAC2 (16), and the degree of decline in HDAC2 activity is closely correlated with the intensity of inflammation (17). Here, HDAC2 is linked to chronic obstructive pulmonary disease.